Abstract:Xiaoou Li, 1 Wei Gao, 2 Zhonglan Jia, 3 Kaihu Yao, 2 Jinyan Yang, 1 Jingjing Tong, 4 Yajuan Wang 5 1 Department of Neonatology, Haidian District Maternal and Child Health Care Hospital, Beijing, 100080, People's Republic of China; 2 Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Laboratory of Dermatology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China; 3 Department of Clinical Laboratory, Haidian District Maternal and Child Health Care Hospital, Beijing, 100080, People's Republic of China; 4 Department of Neonatology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100026, People's Republic of China; 5 Department of Neonatology, Children's Hospital, Capital Institute of Pediatrics, Beijing, 100020, People's Republic of China Correspondence: Yajuan Wang, Department of Neonatology, Children's Hospital, Capital Institute of Pediatrics, No. 2 Yabao Road, Chaoyang District, Beijing, 100020, People's Republic of China, Tel +86-10-85695631, Email Purpose: We investigate the drug resistance, serotype and multilocus sequence typing (MLST) of Group B streptococcus (GBS) strains obtained from pregnant women and neonates in a hospital in Beijing. Patients and Methods: In this cross-sectional study, 1470 eligible pregnant women at a gestational age of 35– 37 weeks presented to our department between May 2015 and May 2016 were included. Vaginal and rectal samples from pregnant women together with sampling from neonatal samples were collected to screen GBS. GBS strains were subject to drug resistance and serotype analysis and MLST. Results: GBS strains were isolated from 111 pregnant women (7.6%) and 6 neonates (0.99%) from 606 matched neonates. 102 strains from pregnant women and 3 strains from neonates were included in the drug sensitivity test, serotyping and MLST typing. All these strains were susceptible to ampicillin, penicillin, ceftriaxone, vancomycin, linezolid, and meropenem. Sixty strains (58.8%) showed multi-drug resistance. Serious cross-resistance was seen between erythromycin and clindamycin. There were eight serotypes, and 37 strains (36.3%) showed a serotype of type III serving as the major type. All 102 GBS strains isolated from pregnant samples could be divided into 18 STs types. They belonged to five clonal complexes and five single clones, with the predominant type of ST19/III, ST10/Ib, and ST23/Ia, with CC19 as the most common type. Three GBS strains isolated from neonates covered two serotypes (ie type III and Ia) that were consistent with those of the mothers. Conclusion: Serotype III was the predominant serotype of GBS in this study. The predominant MLST type was ST19, ST10, and ST23, with ST19/III, ST10/Ib, and ST23/Ia serving as the most prevalent and CC19 as the most common clonal complex. GBS strains from neonates were consistent in the clonal complex, serotype, and MLST with these isolated from the mothers. Keywords: Group B streptococcus, multilocus sequence typing, drug resistance, molecular epidemiology Group B streptococcus (GBS), a gram-positive bacterium commonly colonized in the gastrointestinal and genitourinary tracts, is the leading cause of serious neonatal infection. 1 According to the CDC guidelines, GBS screening is recommended at a gestational age of 35–37 weeks, and most GBS infection can be prevented using universal screening followed by intrapartum antimicrobial prophylaxis (IAP). 2 The utilization of IAP reduces the incidence of early onset GBS disease (GBS-EOD) significantly, but antibiotics may also trigger infection of drug-resistant strains. Penicillin has been preferred for the prevention and treatment of GBS infection as GBS strains are susceptible to penicillin. 3 However, there are few studies reporting decreased susceptibility to penicillin. 4,5 Indeed, the application of antibiotics triggers significant decline in the postnatal infection and neonatal diseases, together with the incidence of severe conditions and even mortality, but it may increase the risk of drug resistance and dissemination. Meanwhile, a high proportion of GBS is resistant to erythromycin, clindamycin, tetracycline, and quinolones, which raises a challenge for the management of GBS infection. 6 In mainland China, the colonization rate of GBS varies in different geographic locations, and there is no exact consensus on the GBS screening in China. In a recent study, the GBS colonization rate in C -Abstract Truncated-

Colonization of Streptococcus agalactiae among pregnant patients in Trinidad and Tobago

[Rapid Group B Streptococcus Screening Methods in Late Pregnancy and the Maternal-Neonatal Outcomes].

High group B streptococcus carriage rates in pregnant women in a tertiary institution in Nigeria

Multidrug Resistant Group B Streptococcus Isolates from Pregnant Women in Delta State, Nigeria

Unravelling Streptococcus agalactiae : Serotype distribution, virulence factors, obstetrics history and clinical presentation correlations in tertiary care hospitals of the western province of Sri Lanka

Prevalence of group B Streptococcus colonisation in mother-newborn dyads in low-income and middle-income south Asian and African countries: a prospective, observational study

Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study

Prevalence and Antibiotic Resistance of Streptococcus agalactiae in Women of Childbearing Age Presenting Urinary Tract Infections from Western Romania

Antimicrobial resistance and molecular characterization of Streptococcus agalactiae from pregnant women in southern China

Antimicrobial Resistance Profile of Group B Streptococci Colonization in a Sample Population of Pregnant Women from Romania

The Risk Factors for Group B Streptococcus Colonization During Pregnancy and Influences of Intrapartum Antibiotic Prophylaxis on Maternal and Neonatal Outcomes

Characterization of Group B Streptococcus Recovered from Pregnant Women and Newborns Attending in a Hospital in Beijing, China

Vertical Transmission of Group B Streptococcus, Prevalence, Associated Factors, and Antimicrobial Susceptibility Profile among Newborns Delivered at Health Facilities in Jigjiga City, Ethiopia

Anovaginal Colonization by Group B Streptococcus and Streptococcus anginosus among Pregnant Women in Brazil and Its Association with Clinical Features

Attitudes of pregnant women in the Dominican Republic towards a future maternal Group B Streptococcus vaccine

Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses

Rectal and Vaginal Eradication of Streptococcus agalactiae (GBS) in Pregnant Women by Using Lactobacillus salivarius CECT 9145, A Target-specific Probiotic Strain

Capsular gene distribution and RAPD typing of Streptococcus agalactiae isolated from pregnant women

[Detection of Maternal Colonization of Group B Streptococcus in Late Pregnancy by Real-Time Polymerase Chain Reaction and Its Effect on Perinatal Outcome].

Characterization of clinical infection and drug resistance of group B streptococcus in Chengdu, China

Molecular Epidemiology of Group B Streptococcus Isolates from Pregnant Women with Premature Rupture of Membranes in Fuzhou, China